1 June 2012 in Cellular Signalling
1 September 2004 in Journal of Biological Chemistry
JPJuana M. García Pedrero
Melatonin is an indole hormone produced mainly by the pineal gland. We have previously demonstrated that melatonin interferes with estrogen (E2) signaling in MCF7 cells by impairing estrogen receptor (ER) pathways. Here we present the characterization of its mechanism of action showing that melatonin is a specific inhibitor of E2-induced ERα-mediated transcription in both estrogen response element- and AP1-containing promoters, whereas ERβ-mediated transactivation is not inhibited or even activated at certain promoters. We show that the sensitivity of MCF-7 cells to melatonin depends on the ERα/ERβ ratio, and ectopic expression of ERβ results in MCF-7 cells becoming insensitive to this hormone. Melatonin acts as a calmodulin antagonist inducing conformational changes in the ERα-calmodulin (CaM) complex, thus impairing the binding of E2·ERα·CaM complex to DNA and, therefore, preventing ERα-dependent transcription. Moreover the mutant ERα (K302G,K303G), unable to bind calmodulin, becomes insensitive to melatonin. The effect of melatonin is specific since other related indoles neither interact with CaM nor inhibit ERα-mediated transactivation. Interestingly, melatonin does not affect the binding of coactivators to ERα, indicating that melatonin action is different from that of current therapeutic anti-estrogens used in breast cancer therapy. Thus, they target ERα at different levels, representing two independent ways to control ERα activity. It is, therefore, conceivably a synergistic pharmacological effect of melatonin and current anti-estrogen drugs.
1 May 1999 in The FASEB Journal
1 April 1982 in European Journal of Biochemistry
The electrochemical gradient of protons (ΔμΔH+) across the plasma membrane of Saccharomyces× 17/17 has been measured as a function of external pH and the external potassium concentration. The proton gradient (ΔpH) has been determined from the distribution of the weak permeable [14C]propionic acid across the plasma membrane. The accumulation of the lipophilic cation [3H]tetraphenylphosphonium has been used to calculate the membrane potential (ΔΨ). It has been observed that yeast cells are able to maintain a ΔμH+ whose values vary from −150 mV at pH 4.5 to −90 mV at pH 7.0. When considered independently ΔpH and ΔΨ have values which vary reciprocally depending on the external pH. At pH 4.5 δpH is the main component of ΔμH+ having a value of −105 mV. Then its value decreases as the external pH increases reaching a value of −10 mV at pH 7.0. At this pH ΔΨ is the main cornponcnt of δμ,H++ having a value of −80 mV, while at pH 4.5 its value is −45 mV. As the external concentration of potassium increases the value of ΔΨ becomes smaller. This decrease in ΔΨ is accompanied by an increase in the value of ΔpH. For any given concentration of potassium, the decrease in ΔΨ is larger than the increase in δpH the net result being, therefore, a decrease in the protonmotive force. In cells treated with the protonophores carbonylcyanide M‐chlorophenylhydrazone or dinitrophenol, δpH is drastically reduced at every pH while ΔΨ is not significantly changed. Upon treatment with dicyclohexylcarbodiimide ΔpH is reduced at any pH tested. This decrease is accompanied by an increase in the value of ΔΨ so that the total protonmotive force remains essentially constant. If the treatment with dicyclohexylcarbodiiniide is carried out in the presence of 200 mM potassium carbodiimide effect on ΔpH and ΔΨ is abolished. The results show that the movements of H+ and K+ are closely connected and play a central role in the establishment and maintenance of an energized state of the cell. They further suggest that δμH+ regulates the fluxes of protons while ΔμH+ regulates the establishment of a ΔμK+.
1 December 2014 in Cellular Signalling
1 July 2011 in Journal of Biological Chemistry
Tumor necrosis factor receptor 2 (TNFR2) activates transcription factor κB (NF-κB) and c-Jun N-terminal kinase (JNK). The mechanisms mediating these activations are dependent on the recruitment of TNF receptor-associated factor 2 (TRAF2) to the intracellular region of the receptor. TNFR2 also induces TRAF2 degradation. We show that in addition to the well characterized TRAF2 binding motif 402-SKEE-405, the human receptor contains another sequence located at the C-terminal end (amino acids 425-439), which also recruits TRAF2 and activates NF-κB. In addition to that, human TNFR2 contains a conserved region (amino acids 338-379) which is responsible for TRAF2 degradation and therefore of terminating NF-κB signaling. TRAF2 degradation and the lack of NF-κB activation when both TNFR1 and TNFR2 are co-expressed results in an enhanced ability of TNFR1 to induce cell death, showing that the cross-talk between both receptors is of a great biological relevance. Induction of TRAF2 degradation appears to be independent of TRAF2 binding to the receptor. Amino acids 343-TGSSDSS-349 are essential for inducing TRAF2 degradation because deletion mutants of this region or point mutations at serine residues 345 and 346 or 348 and 349 obliterate the ability of TNFR2 to induce TRAF2 degradation.